{
    "2021-10-24": [
        [
            {
                "time": "",
                "original_text": "“药中茅台”至暗时刻：股价腰斩，业绩连续下滑 盈利能力下降",
                "features": {
                    "keywords": [
                        "药中茅台",
                        "股价腰斩",
                        "业绩连续下滑",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药投资标的|“十四五”期间拟建设不少于750个国家临床重点专科项目 默沙东息宁缺货致价格飙涨20倍 微创医疗机器人在港招股",
                "features": {
                    "keywords": [
                        "十四五",
                        "国家临床重点专科",
                        "默沙东",
                        "息宁缺货",
                        "价格飙涨",
                        "微创医疗机器人",
                        "在港招股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}